Bayer down after 'mixed reception' at U.S Supreme Court
** Shares in German pharmaceutical company Bayer BAYGn.DE are down 3.4% in early Frankfurt trade with a local trader pointing to a "mixed reception" at a U.S supreme court hearing ** On Monday, the U.S. supreme court appeared split on Bayer's appeal of a verdict in Missouri awarding $1.25 million to a plaintiff from complications related to Roundup weedkiller ** Up to the previous session's close, shares were up 3.7% YTD (Reporting by Cian Muenster) ((Cian.muenster@thomsonreuters.com))
Recent news on Bayer AG
See all newsBayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)